Home LiteratureArticle Details
PMID: 20847294 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation.

Dethlefsen L, Relman DA

Abstract

The indigenous human microbiota is essential to the health of the host. Although the microbiota can be affected by many features of modern life, we know little about its responses to disturbance, especially repeated disturbances, and how these changes compare with baseline temporal variation. We examined the distal gut microbiota of three individuals over 10 mo that spanned two courses of the antibiotic ciprofloxacin, analyzing more than 1.7 million bacterial 16S rRNA hypervariable region sequences from 52 to 56 samples per subject. Interindividual variation was the major source of variability between samples. Day-to-day temporal variability was evident but constrained around an average community composition that was stable over several months in the absence of deliberate perturbation. The effect of ciprofloxacin on the gut microbiota was profound and rapid, with a loss of diversity and a shift in community composition occurring within 3-4 d of drug initiation. By 1 wk after the end of each course, communities began to return to their initial state, but the return was often incomplete. Although broadly similar, community changes after ciprofloxacin varied among subjects and between the two courses within subjects. In all subjects, the composition of the gut microbiota stabilized by the end of the experiment but was altered from its initial state. As with other ecosystems, the human distal gut microbiome at baseline is a dynamic regimen with a stable average state. Antibiotic perturbation may cause a shift to an alternative stable state, the full consequences of which remain unknown.

MeSH Terms
Base Sequence Biodiversity Ciprofloxacin/pharmacology Colony Count, Microbial Feces/microbiology Humans Intestine, Large/microbiology Metagenome/drug effects,genetics Molecular Sequence Data Principal Component Analysis RNA, Ribosomal, 16S/genetics Sequence Analysis, DNA Time Factors
Chemicals
RNA, Ribosomal, 16S Ciprofloxacin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Dethlefsen Les
Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Relman David A
References (32)
32 references, click to expand
  1. Social evolution theory for microorganisms.
    Nat Rev Microbiol. 2006 Aug;4(8):597-607 PMID: 16845430
  2. An ecological and evolutionary perspective on human-microbe mutualism and disease.
    Nature. 2007 Oct 18;449(7164):811-8 PMID: 17943117
  3. Human intestinal bacteria as reservoirs for antibiotic resistance genes.
    Trends Microbiol. 2004 Sep;12(9):412-6 PMID: 15337162
  4. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens.
    FEMS Microbiol Rev. 2004 Oct;28(4):405-40 PMID: 15374659
  5. Symbiotic gut microbes modulate human metabolic phenotypes.
    Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2117-22 PMID: 18252821
  6. Towards the human intestinal microbiota phylogenetic core.
    Environ Microbiol. 2009 Oct;11(10):2574-84 PMID: 19601958
  7. A core gut microbiome in obese and lean twins.
    Nature. 2009 Jan 22;457(7228):480-4 PMID: 19043404
  8. Proposal of Roseburia faecis sp. nov., Roseburia hominis sp. nov. and Roseburia inulinivorans sp. nov., based on isolates from human faeces.
    Int J Syst Evol Microbiol. 2006 Oct;56(Pt 10):2437-2441 PMID: 17012576
  9. The human microbiome project.
    Nature. 2007 Oct 18;449(7164):804-10 PMID: 17943116
  10. Parametric models for estimating the number of classes.
    Biom J. 2008 Dec;50(6):971-82 PMID: 19067331
  11. Genotypic and phenotypic studies of murine intestinal lactobacilli: species differences in mice with and without colitis.
    Appl Environ Microbiol. 2004 Jan;70(1):558-68 PMID: 14711688
  12. Ecological and evolutionary forces shaping microbial diversity in the human intestine.
    Cell. 2006 Feb 24;124(4):837-48 PMID: 16497592
  13. Mechanisms of disease: the hygiene hypothesis revisited.
    Nat Clin Pract Gastroenterol Hepatol. 2006 May;3(5):275-84 PMID: 16673007
  14. What are the consequences of the disappearing human microbiota?
    Nat Rev Microbiol. 2009 Dec;7(12):887-94 PMID: 19898491
  15. Microbial-gut interactions in health and disease. Antibiotic-associated diarrhoea.
    Best Pract Res Clin Gastroenterol. 2004 Apr;18(2):337-52 PMID: 15123074
  16. Allergic disease and sensitization in Steiner school children.
    J Allergy Clin Immunol. 2006 Jan;117(1):59-66 PMID: 16387585
  17. Bile salt biotransformations by human intestinal bacteria.
    J Lipid Res. 2006 Feb;47(2):241-59 PMID: 16299351
  18. Does antibiotic exposure during infancy lead to development of asthma?: a systematic review and metaanalysis.
    Chest. 2006 Mar;129(3):610-8 PMID: 16537858
  19. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing.
    PLoS Biol. 2008 Nov 18;6(11):e280 PMID: 19018661
  20. Interactions and competition within the microbial community of the human colon: links between diet and health.
    Environ Microbiol. 2007 May;9(5):1101-11 PMID: 17472627
  21. Probiotics affect virulence-related gene expression in Escherichia coli O157:H7.
    Appl Environ Microbiol. 2007 Jul;73(13):4259-67 PMID: 17496132
  22. UniFrac--an online tool for comparing microbial community diversity in a phylogenetic context.
    BMC Bioinformatics. 2006 Aug 07;7:371 PMID: 16893466
  23. A general model for the evolution of mutualisms.
    J Evol Biol. 2006 Jul;19(4):1283-93 PMID: 16780529
  24. Probiotics to prevent urinary tract infections: the rationale and evidence.
    World J Urol. 2006 Feb;24(1):28-32 PMID: 16389539
  25. Lactobacillus casei DN-114 001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn's disease patients to adhere to and to invade intestinal epithelial cells.
    Appl Environ Microbiol. 2005 Jun;71(6):2880-7 PMID: 15932981
  26. SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB.
    Nucleic Acids Res. 2007;35(21):7188-96 PMID: 17947321
  27. Roseburia intestinalis sp. nov., a novel saccharolytic, butyrate-producing bacterium from human faeces.
    Int J Syst Evol Microbiol. 2002 Sep;52(Pt 5):1615-1620 PMID: 12361264
  28. The evolution of cooperation.
    Q Rev Biol. 2004 Jun;79(2):135-60 PMID: 15232949
  29. Social strife in the microbial world.
    Trends Microbiol. 2003 Jul;11(7):330-7 PMID: 12875817
  30. Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes.
    DNA Res. 2007 Aug 31;14(4):169-81 PMID: 17916580
  31. Partitioning diversity into independent alpha and beta components.
    Ecology. 2007 Oct;88(10):2427-39 PMID: 18027744
  32. Functional characterization of the antibiotic resistance reservoir in the human microflora.
    Science. 2009 Aug 28;325(5944):1128-1131 PMID: 19713526
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
1091-6490
Published
2011-03-15
Epub
2010-00-16
Pages
4554-61
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC3063582
Subset
IM
Grants
NIH HHS · DP1 OD000964 · United States
NIH HHS · DP1 OD000964-05 · United States
NIH HHS · DP1OD000964 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]